Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic (Stage IV) Melanoma”

483 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 483 results

Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06204991
What this trial is testing

To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVMelanoma
Inge Marie Svane 10
Testing effectiveness (Phase 2)Study completedNCT00669019
What this trial is testing

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Study completedNCT00019994
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT00037037
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00084656
What this trial is testing

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Bristol-Myers Squibb 77
Large-scale testing (Phase 3)Study completedNCT00019682
What this trial is testing

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA Skin MelanomaStage IIIB Skin Melanoma+2 more
National Cancer Institute (NCI) 185
Testing effectiveness (Phase 2)Study completedNCT00004141
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Chicago 46
Testing effectiveness (Phase 2)Study completedNCT00022464
What this trial is testing

CCI-779 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
City of Hope Medical Center
Early research (Phase 1)Study completedNCT01690377
What this trial is testing

Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984328
What this trial is testing

Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

Who this might be right for
Cutaneous MelanomaRelapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID)Metastatic Cutaneous Melanoma (Stage IV)
Genmab 1
Large-scale testing (Phase 3)Active Not RecruitingNCT04657991
What this trial is testing

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Pfizer 257
Large-scale testing (Phase 3)Study completedNCT01227889
What this trial is testing

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

Who this might be right for
Cancer
GlaxoSmithKline 251
Early research (Phase 1)Study completedNCT00798629
What this trial is testing

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 13
Not applicableStudy completedNCT02133222
What this trial is testing

Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

Who this might be right for
Metastatic (Stage IV) Melanoma
Centre Hospitalier Universitaire de Nice 22
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Study completedNCT00054535
What this trial is testing

Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Not applicableStudy completedNCT01010984
What this trial is testing

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

Who this might be right for
Stage IV Melanoma
Robert C. Martin 20
Testing effectiveness (Phase 2)Study completedNCT00450255
What this trial is testing

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+5 more
National Cancer Institute (NCI) 41
Load More Results